The global Nasal Drug Delivery Technology Market was valued at USD 43.89 billion in 2016 and is projected to reach USD 75.61 billion by 2025, growing at a CAGR of 6.23% from 2017 to 2025.
The nasal drug delivery market is increasing due to number of reason, increase in geriatric population and ease of self-administration and efficacy being some of them. The market is growing and expected to observe the same growth pattern all over the globe due to increase in demand and major lifestyle changes coupled with environmental factor (increasing air pollution and infections, air borne diseases).
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing demand of the drug delivery trough nasal cavity because of easy administration
1.2 Growing adoption of self-administration of medicines
2. Market Restraints
2.1 Risks associated with overuse of the medicine
Market Segmentation:
1. Global Nasal Drug Delivery Technology Market, by Containers:
1.1 Non-Pressurized Containers
1.2 Pressurized Containers
2. Global Nasal Drug Delivery Technology Market, by Dosage form:
2.1 Nasal Spray
2.2 Nasal Drops and Liquids
2.3 Nasal Gels
2.4 Nasal Powders
2.5 Others
3. Global Nasal Drug Delivery Technology Market, by Systems:
3.1 Multi Dose
3.2 Bi-Dose
3.3 Unit Dose
4. Global Nasal Drug Delivery Technology Market, by End User:
4.1 Hospitals
4.2 Home Health Care
5. Global Nasal Drug Delivery Technology Market, by Therapeutic Application:
5.1 Allergic and Non-Allergic Rhinitis
5.2 Nasal Congestion
5.3 Vaccinations
5.4 Other Applications
6. Global Nasal Drug Delivery Technology Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Merck & Co., Inc.
2. Novartis AG
3. Glaxosmithkline PLC
4. Johnson & Johnson Services, Inc.
5. Pfizer Inc.
6. Astrazeneca PLC
7. Aptargroup, Inc.
8. Aegis Therapeutics LLC
9. 3M
10. Becton, Dickinson and Company
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Nasal Drug Delivery Technology Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY CONTAINERS
5.1 Overview
5.2 Non-Pressurized Containers
5.3 Pressurized Containers
6 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM
6.1 Overview
6.2 Nasal Spray
6.3 Nasal Drops and Liquids
6.4 Nasal Gels
6.5 Nasal Powders
6.6 Others
7 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY SYSTEMS
7.1 Overview
7.2 Multi Dose
7.3 Bi-Dose
7.4 Unit Dose
8 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY END USER
8.1 Overview
8.2 Hospitals
8.3 Home Health Care
9 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY THERAPEUTIC APPLICATION
9.1 Overview
9.2 Allergic and Non-Allergic Rhinitis
9.3 Nasal Congestion
9.4 Vaccinations
9.5 Other Applications
10 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
11 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Merck & Co., Inc.
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Novartis AG
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Glaxosmithkline PLC
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Johnson & Johnson Services, Inc.
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Pfizer Inc.
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Astrazeneca PLC
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 Aptargroup, Inc.
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Aegis Therapeutics LLC
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 3M
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments
12.10 Becton, Dickinson and Company
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments
13 Appendix
13.1 Related Reports
The Nanobubble Technology Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Industrial Drone Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Autonomous Cargo Delivery Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
Market Overview
The Asia Pacific AI-Enabled Biometric Market is set to experience robust growth from 2024 to 2034, driven by the increasing adoption of artificial intelligence (AI) technologies in biometric systems to enhance security, identity verification, and surveillance. The market...
Market Overview
The Europe AI-Enabled Biometric Market is expected to experience substantial growth from 2024 to 2034, driven by the rising demand for enhanced security systems, increasing adoption of artificial intelligence (AI) technologies, and the need for more efficient biometric i...
Market Overview
The North America AI-Enabled Biometric Market is projected to experience substantial growth from 2024 to 2034, driven by the increasing demand for advanced, secure, and convenient identity verification solutions across various sectors. With rising adoption in areas such ...
Market Overview
The Global AI-Enabled Biometric Market is anticipated to experience substantial growth from 2024 to 2034, propelled by advancements in artificial intelligence, increasing security concerns, and the need for more accurate and efficient identity verification methods. In 20...
Market Overview
The Asia Pacific Passive Optical Network (PON) Market is poised for robust growth between 2024 and 2034, driven by the increasing demand for high-speed broadband connectivity, especially in emerging economies. The market is expected to reach USD XX.XX billion by 2034, gr...
Market Overview
The Europe Passive Optical Network (PON) Market is anticipated to experience significant growth from 2024 to 2034, driven by the increasing demand for high-speed internet, data services, and the transition towards fiber-based broadband solutions. As fiber-optic networks ...
Market Overview
The North America Passive Optical Network (PON) Market is set to experience substantial growth from 2024 to 2034, fueled by increasing investments in fiber-optic infrastructure and growing demand for high-speed, reliable internet connectivity. Projected to reach USD XXX....